Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Climb Bio (CLYM) Preferred Dividend Payments (2020 - 2021)

Climb Bio filings provide 2 years of Preferred Dividend Payments readings, the most recent being $1.3 million for Q3 2021.

  • Quarterly Preferred Dividend Payments rose 186.77% to $1.3 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Jun 2022, down 71.39% year-over-year, with the annual reading at $4.5 million for FY2021, 99.04% up from the prior year.
  • Preferred Dividend Payments hit $1.3 million in Q3 2021 for Climb Bio, down from $2.1 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $2.1 million in Q2 2021 and bottomed at $452000.0 in Q2 2020.